首页
订购/客服:400-666-5481

CADD522

    
98.80%

CADD522

源叶(MedMol)
S87665 一键复制产品信息
199735-88-1
C₁₅H₁₃Cl₂NO₃
326.17
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S87665-5mg买3赠1
98.80%

¥150.00

4 - - - -
S87665-10mg买3赠1
98.80%

¥280.00

4 - - - -
S87665-25mg买3赠1
98.80%

¥540.00

7 - - - -
S87665-100mg
≥98%

¥1390.00

货期:2-3天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: CADD522 is a RUNX2-DNA binding inhibitor (downregulates RUNX2-mediated transcription of downstream target genes), with an IC50 of 10 nM. CADD522 inhibits primary tumor growth and experimental metastasis of tumor cells in the lungs of immune-compromised mice. CADD522 can be used in study of cancer
靶点: RUNX2-DNA binding
体内研究: CADD522 (1, 5 and 20 mg/kg; i.p.; twice a week for 45 days) delays the onset of the tumors and suppresses tumor growth in mice.CADD522 (10 mg/kg; i.p.; twice a week for 11 days) suppresses tumor metastasis and inhibits expression of Ki-67 in mice. Animal Model: Female mice (6-week-old; MMTV-PyMT transgenic model). Dosage: 1, 5 and 20 mg/kg Administration: Intraperitoneal injection; twice a week for 45 days. Result: Delayed the onset of the tumors, delayed tumor development and reduced tumor burden in transgenic MMTV-PyMT mice.Reduced the tumor weight in mice.
参考文献: 1. Kim MS, et al. Characterization of CADD522, a small molecule that inhibits RUNX2-DNA binding and exhibits antitumor activity. Oncotarget. 2017 Aug 10;8(41):70916-70940. 2. Kim MS, et al. Targeting breast cancer metabolism with a novel inhibitor of mitochondrial ATP synthesis. Oncotarget. 2020 Oct 27;11(43):3863-3885.
溶解性: Soluble  in  DMSO
保存条件: 2-8℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 3.066 ml 15.329 ml 30.659 ml
5 mM 0.613 ml 3.066 ml 6.132 ml
10 mM 0.307 ml 1.533 ml 3.066 ml
50 mM 0.061 ml 0.307 ml 0.613 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×